Interleukin 6 Blockade as Steroid-sparing Treatment for 2 Patients with Giant Cell Arteritis

被引：51
|
作者：
Sciascia, Savino [1 ]
Rossi, Daniela [1 ]
Roccatello, Dario [1 ]
机构：
[1] Univ Turin, Ctr Ric Immunopatol & Documentaz Malatti Rare CMI, Dipartimento Malattie Rare Immunol Ematol & Immun, Direz Univ Immunol Clin Osped, I-10154 Turin, Italy
来源：
JOURNAL OF RHEUMATOLOGY | 2011年 / 38卷 / 09期
关键词：
PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; METHOTREXATE; ARTHRITIS;
D O I：
10.3899/jrheum.110496
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2080 / 2082
页数：3
相关论文
共 50 条
  • [31] Targeting Interleukin-6 in the treatment of giant cell arteritis: hope or hype?
    Czihal, Michael
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2016, 45 (05) : 427 - 427
  • [32] IV STEROID TREATMENT OF GIANT-CELL ARTERITIS
    DIAMOND, JP
    OPHTHALMOLOGY, 1993, 100 (03) : 291 - 292
  • [33] Results of a Randomized Controlled Study of Adalimumab for Steroid Sparing in Patients with Giant-Cell Arteritis.
    Mariette, Xavier
    Baron, Gabriel
    Hachulla, Eric
    DeBandt, Michel
    Larroche, C.
    Puechal, Xavier
    Maurier, Francois
    de Wazieres, B.
    Quemeneur, T.
    Ravaud, Philippe
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S589 - S589
  • [34] Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial
    Seror, Raphaele
    Baron, Gabriel
    Hachulla, Eric
    Debandt, Michel
    Larroche, Claire
    Puechal, Xavier
    Maurier, Francois
    de Wazieres, Benoit
    Quemeneur, Thomas
    Ravaud, Philippe
    Mariette, Xavier
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (12) : 2074 - 2081
  • [35] Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect
    Chen, D. M.
    Odueyungbo, A.
    Csinady, E.
    Gearhart, L.
    Lehane, P.
    Cheu, M.
    Maho-Vaillant, M.
    Prost-Squarcioni, C.
    Hebert, V
    Houivet, E.
    Calbo, S.
    Caillot, F.
    Golinski, M. L.
    Labeille, B.
    Picard-Dahan, C.
    Paul, C.
    Richard, M. A.
    Bouaziz, J. D.
    Duvert-Lehembre, S.
    Bernard, P.
    Caux, F.
    Alexandre, M.
    Ingen-Housz-Oro, S.
    Vabres, P.
    Delaporte, E.
    Quereux, G.
    Dupuy, A.
    Debarbieux, S.
    Avenel-Audran, M.
    D'Incan, M.
    Bedane, C.
    Beneton, N.
    Jullien, D.
    Dupin, N.
    Misery, L.
    Machet, L.
    Beylot-Barry, M.
    Dereure, O.
    Sassolas, B.
    Benichou, J.
    Musette, P.
    Joly, P.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (05) : 1111 - 1119
  • [36] Steroid-sparing agents for the treatment of inflammation in complicated neurocysticercosis
    Anand, Pria
    Mukerji, Shibani
    Thon, Jesse
    Gunaratne, Shauna
    Cho, Tracey
    Venna, Nagagopal
    NEUROLOGY, 2020, 94 (15)
  • [37] Steroid-sparing agents for the treatment of inflammation in complicated neurocysticercosis
    Anand, Pria
    Mukerji, Shibani S.
    Thon, Jesse
    Gunaratne, Shauna
    Cho, Tracey A.
    Venna, Nagagopal
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2019, 6 (06):
  • [38] Simvastatin in the treatment of asthma: lack of steroid-sparing effect
    Cowan, Douglas C.
    Cowan, Jan O.
    Palmay, Rochelle
    Williamson, Avis
    Taylor, D. Robin
    THORAX, 2010, 65 (10) : 891 - 896
  • [39] Doxofylline as a steroid-sparing treatment in Mexican children with asthma
    Gonzalez-Diaz, Sandra Nora
    Ansotegui, Ignacio J.
    Macouzet-Sanchez, Carlos
    Acuna-Ortega, Natalhie
    de la Cruz--de la Cruz, Carlos
    JOURNAL OF ASTHMA, 2024, 61 (06) : 574 - 583
  • [40] Interleukin-6: a promising target for the treatment of polymyalgia rheumatica or giant cell arteritis?
    Toussirot, Eric
    Regent, Alexis
    Devauchelle-Pensec, Valerie
    Saraux, Alain
    Puechal, Xavier
    RMD OPEN, 2016, 2 (02):
12345